What is Opsoclonus Myoclonus Ataxia Syndrome (OMAS)?
Opsoclonus Myoclonus Ataxia syndrome (OMAS) is a type of autoimmune disease. OMAS affects the brain, nerves and eyes.
Opsoclonus Myoclonus Ataxia syndrome (OMAS) is a type of autoimmune disease. OMAS affects the brain, nerves and eyes.
The body’s immune system protects it from foreign objects. With an autoimmune disorder, the immune system doesn’t recognize its own healthy tissue and attacks it.
OMAS is not present at birth. It develops as the immune system matures. It often starts to show during early childhood years, with most patients developing symptoms around 2 years old.
Treatment of OMAS is designed to calm down the immune system. It is important to maintain the best possible health, function and movement. Typically, children who have OMAS have a good recovery, and it’s rare that it will happen again, but it sometimes can. Some patients have lasting cognitive problems, such as inattention or difficulty with school. A child may not get back certain movements or functions.
There are several causes of OMAS. Around half of patients with OMAS have a tumor (commonly a neuroblastoma). Other causes are infection (such as strep, monovirus, COVID-19) or metabolic disorders. Sometimes there is no known cause for OMAS, and it is called idiopathic OMAS.
Symptoms can be different from child to child. Not all children will have all of the symptoms listed.
Common symptoms for OMAS in children include:
A neurologist is a doctor who specializes in conditions that affect the brain and nerves. The doctor will ask about symptoms and do a neurologic exam. The doctor tests vision, hearing, sensation, strength and swallowing. Coordination, balance and reflexes also are tested.
To confirm that a child has OMAS, doctors use additional tests. The main tests are:
The categories of OMAS treatment include:
Children with OMAS stay on medication to help prevent further relapses. Doctors will watch closely for new symptoms and help decide when treatment can be stopped. Repeated brain MRIs may also be recommended.
Many patients may only have one OMAS attack, and most children recover well with timely therapy. The risk of having another OMAS attack after the first event is around 40%. After an attack, patients often have ongoing disabilities. The most common lingering symptom is cognitive impairment, including inattention and behavioral dysregulation. Children may need psychological or psychiatric treatment to manage symptoms. With treatment and prevention of relapses, most children do not develop significant disability from OMAS.
Last Updated 08/2025
Learn more about our editorial policy.